Abstract
ObjectiveIntravenous iron—a common treatment for anaemia and iron deficiency due to inflammatory bowel disease (IBD)—can cause hypophosphataemia. This trial compared the incidence of hypophosphataemia after treatment with ferric carboxymaltose (FCM)...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have